Home
Matrix Capital Management Company reported a 3.5% stake in Maze Therapeutics MAZE · 1,653,684 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.5%
- Last report
- 5.7% · filed 25/05/14
- Shares held
- 1,653,684 sh
- Class
- Common Stock, par value $0.001 per share
- Event date
- 25/09/30
- Filed
- 25/11/13
3.5% stake · below 5%
- Stake
- 3.5%
- Last report
- 5.7%
- Since last report
- −2.2pp
Maze Therapeutics trades, last 26 weeks
What else happened in Maze Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Matrix Capital Management Company's other 5% stake reports
- Matrix Capital Management Company
5% stakeAura Biosciences
5% stakeAura Biosciences
AURA
0% stake
0 sh
0% stake
Filed 05/11
- Matrix Capital Management Company
5% stakeZentalis Pharmaceuticals
5% stakeZentalis Pharmaceuticals
ZNTL
0% stake
0 sh
0% stake
Filed 01/02
- Matrix Capital Management Company
5% stakeZentalis Pharmaceuticals
5% stakeZentalis Pharmaceuticals
ZNTL
9.98% stake
6,459,973 sh
9.98% stake
Filed 25/12/15
- Matrix Capital Management Company
5% stakeAura Biosciences
5% stakeAura Biosciences
AURA
11.17% stake
6,922,870 sh
11.17% stake
Filed 25/05/19
- Matrix Capital Management Company
5% stakeMaze Therapeutics
5% stakeMaze Therapeutics
MAZE
5.7% stake
2,486,184 sh
5.7% stake
Filed 25/05/14
